Canadian reactor to reopen

A linkurl:shuttered;http://www.the-scientist.com/blog/display/54006/ Canadian nuclear reactor that normally produces radioisotopes crucial to a variety of medical diagnoses will reopen soon. Emergency legislation linkurl:passed;http://www.thestar.com/News/Canada/article/285209 by the Canadian government late Tuesday (Dec 11) will allow the reactor to open for 120 days and resume production of the isotopes. Canada's Prime Minister, Stephen Harper, was apparently none too happy with the parties

Written byBob Grant
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share
A linkurl:shuttered;http://www.the-scientist.com/blog/display/54006/ Canadian nuclear reactor that normally produces radioisotopes crucial to a variety of medical diagnoses will reopen soon. Emergency legislation linkurl:passed;http://www.thestar.com/News/Canada/article/285209 by the Canadian government late Tuesday (Dec 11) will allow the reactor to open for 120 days and resume production of the isotopes. Canada's Prime Minister, Stephen Harper, was apparently none too happy with the parties involved in the reactor's closing. "I can certainly assure the House that when this is all behind us," Harper told the __Toronto Star__, "the government will carefully examine the role of all actors in this incident and make sure that accountability is appropriately restored." The reactor's prolonged closure has caused a shortage of the isotope technetium-99 in hospitals, where it is used to diagnose cancers, heart and kidney problems among other ailments. Scientists I've contacted who use technetium-99 in their research have not yet experienced interruptions to their work. The company that operates the reactor originally linkurl:estimated;http://www.newscientist.com/article/dn13025-nuclear-plant-shutdown-brings-hospital-delays.html that the reactor would not reopen until January, 2008.
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

  • From 2017 to 2022, Bob Grant was Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer. Before joining the team, he worked as a reporter at Audubon and earned a master’s degree in science journalism from New York University. In his previous life, he pursued a career in science, getting a bachelor’s degree in wildlife biology from Montana State University and a master’s degree in marine biology from the College of Charleston in South Carolina. Bob edited Reading Frames and other sections of the magazine.

    View Full Profile
Share
July Digest 2025
July 2025, Issue 1

What Causes an Earworm?

Memory-enhancing neural networks may also drive involuntary musical loops in the brain.

View this Issue
Accelerating Recombinase Reprogramming with Machine Learning

Accelerating Recombinase Reprogramming with Machine Learning

Genome Modeling and Design: From the Molecular to Genome Scale

Genome Modeling and Design: From the Molecular to Genome Scale

Twist Bio 
Screening 3D Brain Cell Cultures for Drug Discovery

Screening 3D Brain Cell Cultures for Drug Discovery

DNA and pills, conceptual illustration of the relationship between genetics and therapeutic development

Multiplexing PCR Technologies for Biopharmaceutical Research

Thermo Fisher Logo

Products

waters-logo

Waters and BD's Biosciences & Diagnostic Solutions Business to Combine, Creating a Life Science and Diagnostics Leader Focused on Regulated, High-Volume Testing

zymo-research-logo

Zymo Research Partners with Harvard University to Bring the BioFestival to Cambridge, Empowering World-class Research

10x-genomics-logo

10x Genomics and A*STAR Genome Institute of Singapore Launch TISHUMAP Study to Advance AI-Driven Drug Target Discovery

The Scientist Placeholder Image

Sino Biological Sets New Industry Standard with ProPure Endotoxin-Free Proteins made in the USA